Piper Jaffray Starts Cytokinetics (CYTK) at Overweight
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $73.95 --0%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 4
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 4
Join SI Premium – FREE
Piper Jaffray initiates coverage on Cytokinetics (NASDAQ: CYTK) with a Overweight. PT $4.00.
For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.
Shares of Cytokinetics closed at $0.67 yesterday.
For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.
Shares of Cytokinetics closed at $0.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Starts Lennar (LEN) at Hold
- Barclays Starts Gaztransport & Technigaz (GTT:FP) at Overweight
- Cytokinetics aficamten shows cardiac benefits in two HCM trial analyses
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
